Deep Lens' patient identification solutions accelerate oncology clinical trial enrollment by connecting trial sponsors to community oncology practices at scale.
Precision medicine changed the game in oncology clinical trials. Biomarkers can confidently identify eligible patients, but result in competition for patients at care sites.
By focusing on community oncology, Deep Lens is helping to open new doors for clinical trial managers. The result is as much as a 300% increase in accrual rates. Learn more about how we accelerate clinical trials below.
The Deep Lens Unity Network is the fastest growing community oncology network in the country. Check out all the benefits of membership here.
Dedicated clinical research coordinators work with care teams to pre-screen eligible patients. Spend more time on patient care and less on chart review.
VIPER is Deep Lens’ AI-powered platform that identifies patients based on trial criteria. Easy to use dashboards ensure your enrollment goals stay on track.
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)